CT and MRI multimodality imaging features of endometrial stromal sarcoma: a retrospective single-center analysis of 35 pathologically confirmed cases
5 affiliations
- 1Department of Radiology, The First Affiliated Hospital of Guangxi Medical University
- 2Department of Radiology, The Affiliated Hospital of Qingdao University
- 3Department of Radiology, Liuzhou People’s Hospital Affiliated to Guangxi Medical University
- 4Department of Radiology, Affiliated Hospital of Guilin Medical University
- 5Department of Pathology, The Affiliated Hospital of Qingdao University
Abstract
Objective: Endometrial stromal sarcoma (ESS) is an uncommon malignant neoplasm within the female reproductive system. This tumor arises from the stromal cells of the endometrium and ranks as the second most prevalent type of malignant mesenchymal tumor in the uterus, following leiomyosarcoma. It constitutes approximately 1% of all female genital tract cancers and accounts for 3–9% of uterine neoplasms. The clinical specificity of ESS is poor, its imaging manifestations are diverse, and early diagnosis is difficult, relying on pathological confirmation.
Methods: In this retrospective single-center study, we analyzed the CT and MRI imaging findings of 35 pathologically confirmed ESS cases (26 low-grade, 9 high-grade) to identify characteristic imaging features and subgroup differences.
Results: Key findings included the uterine rupture/channel sign (observed in 7 of 21 endometrial-involved cases), honeycomb-like vascular shadows (5 cases), and progressive centripetal homogeneous enhancement (2 cases). Low grade ESS tended to present with larger tumors and more frequent extensive pelvic invasion (mean diameter 10.76 ± 6.58 cm vs. 6.57 ± 1.51 cm, P = 0.007), while high grade ESS more commonly presented with abdominal pain (P = 0.013) and elevated CA19-9 (P = 0.013).
Conclusion: These imaging signs may provide auxiliary clues for preoperative suspicion of ESS; however, definitive diagnosis remains dependent on postoperative pathology and immunohistochemistry. Due to the single-center design, small sample size, and lack of a control group, the diagnostic specificity of these signs requires further validation in multicenter prospective studies.
Related
- CD163-positive macrophage enrichment is associated with mismatch repair deficiency and adverse pathologic features in early-stage endometrioid endometrial carcinoma: a retrospective cohort study
- Multimodality imaging features of dasatinib-induced pulmonary arterial hypertension
- Exploratory Analysis of Age-Associated Somatic Mutation Patterns and Clinicopathologic Features in Endometrial Cancer
- Association of VCP/p97 Expression with Clinicopathological Features and Overall Survival in Endometrioid Endometrial Carcinoma
- Comparative performance of pre- and post-endoscopic risk scores for outcome prediction in endoscopy-confirmed upper gastrointestinal bleeding in the emergency department : A retrospective single-center study
BibTeX
@article{yu2026multimodality,
title = {{CT and MRI multimodality imaging features of endometrial stromal sarcoma: a retrospective single-center analysis of 35 pathologically confirmed cases}},
author = {Lan Yu and Meizhen Xie and Yan Dong and Xiaoming Zhou and Haiyan Gu and Liling Long},
journal = {Frontiers in Oncology},
year = {2026},
month = oct,
doi = {10.3389/fonc.2026.1847673},
url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1847673/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - CT and MRI multimodality imaging features of endometrial stromal sarcoma: a retrospective single-center analysis of 35 pathologically confirmed cases
AU - Lan Yu
AU - Meizhen Xie
AU - Yan Dong
AU - Xiaoming Zhou
AU - Haiyan Gu
AU - Liling Long
PY - 2026
DA - 2026/10/29
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.1847673
UR - https://www.frontiersin.org/articles/10.3389/fonc.2026.1847673/full
AB - Objective: Endometrial stromal sarcoma (ESS) is an uncommon malignant neoplasm within the female reproductive system. This tumor arises from the stromal cells of the endometrium and ranks as the second most prevalent type of malignant mesenchymal tumor in the uterus, following leiomyosarcoma. It constitutes approximately 1% of all female genital tract cancers and accounts for 3–9% of uterine neoplasms. The clinical specificity of ESS is poor, its imaging manifestations are diverse, and early diagnosis is difficult, relying on pathological confirmation. Methods: In this retrospective single-center study, we analyzed the CT and MRI imaging findings of 35 pathologically confirmed ESS cases (26 low-grade, 9 high-grade) to identify characteristic imaging features and subgroup differences. Results: Key findings included the uterine rupture/channel sign (observed in 7 of 21 endometrial-involved cases), honeycomb-like vascular shadows (5 cases), and progressive centripetal homogeneous enhancement (2 cases). Low grade ESS tended to present with larger tumors and more frequent extensive pelvic invasion (mean diameter 10.76 ± 6.58 cm vs. 6.57 ± 1.51 cm, P = 0.007), while high grade ESS more commonly presented with abdominal pain (P = 0.013) and elevated CA19-9 (P = 0.013). Conclusion: These imaging signs may provide auxiliary clues for preoperative suspicion of ESS; however, definitive diagnosis remains dependent on postoperative pathology and immunohistochemistry. Due to the single-center design, small sample size, and lack of a control group, the diagnostic specificity of these signs requires further validation in multicenter prospective studies.
SN - 2234-943X
ER -